Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ)
CNY 3.42
(0.29%)
CNY 3.42
(0.29%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 9.24 Billion CNY | -5.6% |
| 2022 | 9.79 Billion CNY | 1.71% |
| 2021 | 9.62 Billion CNY | -0.35% |
| 2020 | 9.66 Billion CNY | -7.27% |
| 2019 | 10.41 Billion CNY | -4.01% |
| 2018 | 10.85 Billion CNY | -9.21% |
| 2017 | 11.95 Billion CNY | 10.72% |
| 2016 | 10.79 Billion CNY | 65.98% |
| 2015 | 6.5 Billion CNY | 24.54% |
| 2014 | 5.22 Billion CNY | 251.35% |
| 2013 | 1.48 Billion CNY | 11.39% |
| 2012 | 1.33 Billion CNY | 7.32% |
| 2011 | 1.24 Billion CNY | 10.49% |
| 2010 | 1.12 Billion CNY | 139.29% |
| 2009 | 470.34 Million CNY | 6.24% |
| 2008 | 442.73 Million CNY | 13.21% |
| 2007 | 391.07 Million CNY | 3.09% |
| 2006 | 379.34 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 8.89 Billion CNY | -1.21% |
| 2024 Q2 | 9 Billion CNY | -1.37% |
| 2024 Q1 | 9.13 Billion CNY | -1.24% |
| 2023 Q1 | 9.88 Billion CNY | 0.99% |
| 2023 Q3 | 9.62 Billion CNY | -0.46% |
| 2023 Q4 | 9.24 Billion CNY | -3.97% |
| 2023 FY | 9.24 Billion CNY | -5.6% |
| 2023 Q2 | 9.67 Billion CNY | -2.21% |
| 2022 Q2 | 9.71 Billion CNY | 1.82% |
| 2022 Q3 | 9.95 Billion CNY | 2.42% |
| 2022 Q4 | 9.79 Billion CNY | -1.63% |
| 2022 Q1 | 9.54 Billion CNY | -0.86% |
| 2022 FY | 9.79 Billion CNY | 1.71% |
| 2021 FY | 9.62 Billion CNY | -0.35% |
| 2021 Q3 | 9.61 Billion CNY | -6.96% |
| 2021 Q1 | 9.65 Billion CNY | -0.05% |
| 2021 Q2 | 10.32 Billion CNY | 6.96% |
| 2021 Q4 | 9.62 Billion CNY | 0.19% |
| 2020 Q1 | 10.31 Billion CNY | -0.96% |
| 2020 FY | 9.66 Billion CNY | -7.27% |
| 2020 Q2 | 9.87 Billion CNY | -4.31% |
| 2020 Q3 | 9.89 Billion CNY | 0.23% |
| 2020 Q4 | 9.66 Billion CNY | -2.37% |
| 2019 FY | 10.41 Billion CNY | -4.01% |
| 2019 Q3 | 10.25 Billion CNY | 0.29% |
| 2019 Q2 | 10.22 Billion CNY | -3.71% |
| 2019 Q1 | 10.62 Billion CNY | -2.12% |
| 2019 Q4 | 10.41 Billion CNY | 1.56% |
| 2018 Q4 | 10.85 Billion CNY | -12.54% |
| 2018 FY | 10.85 Billion CNY | -9.21% |
| 2018 Q1 | 11.76 Billion CNY | -1.6% |
| 2018 Q2 | 12.49 Billion CNY | 6.21% |
| 2018 Q3 | 12.41 Billion CNY | -0.68% |
| 2017 Q4 | 11.95 Billion CNY | 2.57% |
| 2017 FY | 11.95 Billion CNY | 10.72% |
| 2017 Q1 | 10.98 Billion CNY | 1.7% |
| 2017 Q2 | 11.48 Billion CNY | 4.59% |
| 2017 Q3 | 11.65 Billion CNY | 1.49% |
| 2016 FY | 10.79 Billion CNY | 65.98% |
| 2016 Q4 | 10.79 Billion CNY | -0.55% |
| 2016 Q3 | 10.85 Billion CNY | 2.97% |
| 2016 Q2 | 10.54 Billion CNY | 2.51% |
| 2016 Q1 | 10.28 Billion CNY | 58.12% |
| 2015 Q3 | 6.33 Billion CNY | 4.75% |
| 2015 Q1 | 5.45 Billion CNY | 4.51% |
| 2015 FY | 6.5 Billion CNY | 24.54% |
| 2015 Q2 | 6.04 Billion CNY | 10.82% |
| 2015 Q4 | 6.5 Billion CNY | 2.65% |
| 2014 Q4 | 5.22 Billion CNY | 7.05% |
| 2014 Q1 | 3.7 Billion CNY | 149.35% |
| 2014 Q2 | 4.51 Billion CNY | 21.8% |
| 2014 FY | 5.22 Billion CNY | 251.35% |
| 2014 Q3 | 4.87 Billion CNY | 8.06% |
| 2013 Q4 | 1.48 Billion CNY | -0.43% |
| 2013 FY | 1.48 Billion CNY | 11.39% |
| 2013 Q1 | 1.33 Billion CNY | 0.14% |
| 2013 Q2 | 1.36 Billion CNY | 2.16% |
| 2013 Q3 | 1.49 Billion CNY | 9.36% |
| 2012 FY | 1.33 Billion CNY | 7.32% |
| 2012 Q3 | 1.27 Billion CNY | 1.0% |
| 2012 Q2 | 1.26 Billion CNY | 1.2% |
| 2012 Q4 | 1.33 Billion CNY | 4.85% |
| 2012 Q1 | 1.24 Billion CNY | 0.14% |
| 2011 Q1 | 1.14 Billion CNY | 2.05% |
| 2011 Q3 | 1.16 Billion CNY | 0.27% |
| 2011 Q4 | 1.24 Billion CNY | 7.11% |
| 2011 FY | 1.24 Billion CNY | 10.49% |
| 2011 Q2 | 1.15 Billion CNY | 0.81% |
| 2010 Q2 | 1.13 Billion CNY | 142.7% |
| 2010 Q3 | 1.11 Billion CNY | -1.49% |
| 2010 Q1 | 468.03 Million CNY | -0.49% |
| 2010 Q4 | 1.12 Billion CNY | 0.58% |
| 2010 FY | 1.12 Billion CNY | 139.29% |
| 2009 FY | 470.34 Million CNY | 6.24% |
| 2009 Q2 | 425.74 Million CNY | 0.0% |
| 2009 Q4 | 470.34 Million CNY | 0.0% |
| 2008 FY | 442.73 Million CNY | 13.21% |
| 2007 FY | 391.07 Million CNY | 3.09% |
| 2006 FY | 379.34 Million CNY | 0.0% |